Author

S. Usuki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

T. Ito· 2 shared A. Matsuo· 1 shared H. Kohrogi· 1 shared H. Niwa· 1 shared H. Saito· 1 shared J. Wakimoto· 1 shared K. Fujino· 1 shared K. Matsuura· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

T. Ito

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ROR1 plays a critical role in pancreatic tumor-initiating cells with a partial EMT signature.

M. Yamazaki, S. Hino, S. Usuki, Y. Miyazaki, T. Oda, M. Nakao, T. Ito, K. Yamagata

This study identifies ROR1 as a critical marker for pancreatic tumor-initiating cells with a partial EMT signature, showing its role in promoting tumor growth and relapse.

The EMBO Journal · Apr 25, 2023Peer-reviewedCancer Biology

Distinct transcriptional programs of SOX2 in different types of small cell lung cancers

Y. Tenjin, K. Matsuura, S. Kudoh, S. Usuki, T. Yamada, A. Matsuo, Y. Sato, H. Saito, K. Fujino, J. Wakimoto, T. Ichimura, H. Kohrogi, T. Sakagami, H. Niwa, T. Ito

This study identifies distinct SOX2 transcriptional programs in different SCLC subtypes and highlights the therapeutic potential of targeting the ASCL1-SOX2 axis in classical SCLC.

bioRxiv · Nov 28, 2019Cancer Biology